Business Context and Reporting Period
Mangoceuticals, Inc. (MGRX), an emerging growth company incorporated in Texas, filed this Form 8-K on July 3, 2025. The report details the establishment of a new class of preferred stock by its wholly-owned subsidiary, Mango & Peaches Corp.
Key Financial Metrics and Capital Structure
This filing does not report operational financial metrics such as revenue, profit, cash flow, or liquidity. The primary financial disclosure concerns the authorization of a new equity instrument:
- Instrument: 6% Series B Convertible Cumulative Preferred Stock.
- Authorized Shares: 1,000,000 shares.
- Stated Value: $10.00 per share.
- Dividend Rate: 6% per annum on the Stated Value, payable quarterly in arrears commencing September 30, 2025.
- Liquidation Preference: Stated Value plus $2.50 per share, plus accrued dividends.
- Redemption Value: $12.50 per share (exercisable after the third anniversary of issuance).
Material Changes
The material change reported is the filing of the Certificate of Designations with the Texas Secretary of State on July 3, 2025, creating the Series B Preferred Stock. This action alters the company's capital structure by introducing a senior security with specific dividend, liquidation, and conversion rights.
Terms, Rights, and Contingencies
Conversion Rights: Holders may convert shares into common stock at a price of $1.50 per share. The conversion amount is the lesser of the Stated Value or $12.50. A beneficial ownership limitation restricts conversion if it would cause a holder to exceed 4.999% of outstanding common stock (increasable to 9.999% with notice).
Voting and Protective Provisions: The stock carries no general voting rights but includes protective provisions requiring majority holder approval for amendments to the designation, issuance of senior securities, or changes adversely affecting the series.
Dividend Settlement: Accrued dividends may be paid in cash or in-kind by increasing the Stated Value.
Risks: The issuance of preferred stock with a liquidation preference senior to common stock may dilute the value of common equity in a liquidation scenario. The 6% dividend obligation, if declared, represents a fixed cost to the company.
Investor Verification Checklist
- Verify the full text of the Certificate of Designations (Exhibit 3.1) for complete legal terms.
- Confirm the actual issuance date and number of shares sold to determine the immediate dividend liability.
- Assess the impact of the 4.999% beneficial ownership limitation on potential future liquidity for preferred holders.
- Review the company's current cash position to evaluate its ability to fund quarterly dividends starting September 30, 2025.